Medical cannabis use in patients with chronic health issues is linked to significant improvements in overall health-related quality of life and fatigue levels. Cannabis therapy is also linked to improvements in anxiety, depression, and pain levels though no changes in sleep disturbance levels rep
Article content
A wide-ranging longitudinal study involving thousands of medical cannabis patients in Australia is trying to get a fix on many related issues, ranging from anxiety to health costs.
University of Sydney researchers have launched The QUality of life Evaluation STudy (The QUEST Initiative), which is set to close in March 2022. The study is being touted as one of the largest in the world to examine the quality of life (QoL) outcomes for patients who use medicinal cannabis, the university announced this week.
We apologize, but this video has failed to load.
Try refreshing your browser, or Patients who use medicinal cannabis to be assessed for changes in quality-of-life outcomes Back to video
Major longitudinal study launched to assess changes in quality-of-life outcomes for patients prescribed medicinal cannabis
Lead researcher Associate Professor Claudia Rutherford. Top of page: Flowering cannabis credit My 450 Tours, Wikimedia Commons.
Researchers at the University of Sydney have launched The QUality of life Evaluation STudy (The QUEST Initiative), a wide-ranging, longitudinal study for medicinal cannabis patients.
The QUEST Initiative aims to be one of the world’s largest studies examining quality of life outcomes in patients prescribed medicinal cannabis. The study aims to recruit at least 2,100 patients – the minimum sample size (number of recruited patients) calculated to achieve statistical relevance – by June 2021 with potential to extend this study internationally.